95 results on '"Ertl, G."'
Search Results
2. Relative longitudinal strain apical sparing pattern and low albumin as detrimental factors of cardiovascular outcome after transcatheter aortic valve replacement
3. 5-year outcome comparison among aortic stenosis patients underwent transcatheter aortic valve implantation with or without permanent pacemaker
4. Sex and marital status modify the effect of remote patient management on mortality risk in patients hospitalized for acute systolic heart failure: Insights from the E-INH study
5. Impact of single-valve and multiple-valve heart disease on long-term outcome in patients with chronic heart failure
6. Real-world drug prescription patterns and mortality risk in patients hospitalized with acute heart hailure: impact of multimorbidity and heart failure phenotype
7. Reduction in systolic pulmonary artery pressure after TAVI is associated with lower cardiovascular mortality in patients with severe aortic stenosis
8. What is the best time interval for health status assessments after discharge? Findings from the E-INH study
9. MR-proADM is a strong independent predictor of long-term all-cause mortality risk in patients with chronic heart failure: results from the E-INH study
10. Mortality risk is increased in chronotropic incompetent device carriers with acute heart failure
11. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV—a survey from the European Society of Cardiology
12. Prevalence, severity and clinical correlates of left ventricular diastolic dysfunction in patients hospitalized with acute cardiac decompensation – a sub-study from the Acute Heart Failure
13. Determinants and prognostic implication of improved left ventricular ejection fraction in chronic heart failure patients with reduced ejection fraction
14. Prognostic value of global longitudinal strain versus mitral annular plane systolic excursion in patients with ischemic heart failure
15. Ischemic heart disease is more prevalent in low-income-countries and more often undertreated: data from report-hf
16. Impact of right and left ventricular dysfunction on long-term outcome of moderate to severe secondary mitral regurgitation patients without surgical/interventional treatment
17. Septal mitral annular systolic excursion but not global longitudinal strain predicts outcome in non-ischemic heart failure patients with reduced ejection fraction and mild diastolic dysfunction
18. ESC Core Curriculum for the General Cardiologist (2013)
19. P4513Impact of right ventricular dysfunction on outcome in heart failure patients with mid-range ejection fraction with and without chronic respiratory diseases
20. P5452First data-analysis of the prospective ETiCS-study after study-end confirms acute (microbial-induced) inflammation as a key trigger for the development of cardiac GPCR-autoantibodies
21. P2612Anaemia and renal impairment in heart failure: prevalence and differential prognostic importance according to the AHA ACC heart failure classification
22. P3551Right ventricular dysfunction in heart failure patients with reduced ejection fraction with and without chronic respiratory diseases: A treacherous combination for the ominous outcome?
23. P3545Association between diastolic dysfunction and two-year survival in heart failure patients with mid-range or reduced left ventricular ejection fraction
24. P5450Evening levels and circadian changes of salivary cortisol predict adverse events in heart failure patients with comorbid depression - a MOOD-HF substudy
25. 2455Predictive value of diastolic dysfunction severity on long-term survival in heart failure patients with mid-range or reduced left ventricular ejection fraction
26. P3753Portable echocardiography in patients with suspected heart failure in primary care. Prevalence and prognostic significance of abnormal findings
27. 4935Biomarker profile of patients with recovery of left ventricular systolic function following acute cardiac decompensation
28. P579Incremental prognostic value of cardiac biomarkers in diagnostically naive patients with suspected heart failure - comparison with a clinical base model
29. P1098Treatment of Fabry disease with a new oral drug: Initial real-world single-center experience
30. P1691Enlarged left atrium is an independent risk factor for long-term mortality in heart failure patients with reduced ejection fraction and received implantable cardioverter defibrillators
31. P6421Role of sudden cardiac death as end-stage complication in Fabry disease cardiomyopathy: Impact of primary and secondary prophylactic ICD therapy on long-term outcome
32. P1100Efficacy of enzyme replacement therapy in Fabry disease with advanced organ involvement
33. P1102Role of serum biomarkers for monitoring disease progression in the cardio-specific alpha-galactosidase A genotype N215S
34. P2619Impact of myocardial fibrosis on 10-year-outcome in patients undergoing aortic valve replacement
35. 4100Selective TRASSI T1 mapping for improved endocardial and right ventricular diagnostics
36. The Year in Cardiology 2013: heart failure
37. Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
38. Prognosis and right ventricular function assessment in chronic heart failure with severe tricuspid regurgitations: doppler-derived systolic pulmonary artery pressure is not enough
39. How to titrate betablocker therapy in heart failure patients?
40. Cognition matters in cardiovascular disease and heart failure
41. Effect of contrast application on interpretability and diagnostic value of dobutamine stress echocardiography in patients with intermediate coronary lesions: comparison with myocardial fractional flow reserve
42. Assessment of the contractile reserve in patients with intermediate coronary lesions: a strain rate imaging study validated by invasive myocardial fractional flow reserve
43. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry
44. Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease
45. Beta-Blockers in Cardiac Failure
46. Cardiac dysfunction and development of heart failure
47. Effect of mediators on coronary circulation
48. Introduction
49. Coronary arteriolar vasoconstriction in myocardial ischaemia. Vasopressin, renin-angiotensin system and ANF
50. Early remodelling of the left ventricle in patients with myocardial infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.